000 | 01901 a2200565 4500 | ||
---|---|---|---|
005 | 20250513235208.0 | ||
264 | 0 | _c20010719 | |
008 | 200107s 0 0 eng d | ||
022 | _a0007-1188 | ||
024 | 7 |
_a10.1038/sj.bjp.0704022 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHaddad, E B | |
245 | 0 | 0 |
_aRole of p38 MAP kinase in LPS-induced airway inflammation in the rat. _h[electronic resource] |
260 |
_bBritish journal of pharmacology _cApr 2001 |
||
300 |
_a1715-24 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAerosols |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
650 | 0 | 4 |
_aBenzamides _xpharmacology |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCytosol _xmetabolism |
650 | 0 | 4 |
_aDexamethasone _xpharmacology |
650 | 0 | 4 | _aEndotoxins |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImidazoles _xpharmacology |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aInterleukin-1 _xmetabolism |
650 | 0 | 4 |
_aLipopolysaccharides _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aMonocytes _xmetabolism |
650 | 0 | 4 |
_aNeutrophils _xdrug effects |
650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aPneumonia _xchemically induced |
650 | 0 | 4 |
_aPyridines _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
650 | 0 | 4 | _ap38 Mitogen-Activated Protein Kinases |
700 | 1 | _aBirrell, M | |
700 | 1 | _aMcCluskie, K | |
700 | 1 | _aLing, A | |
700 | 1 | _aWebber, S E | |
700 | 1 | _aFoster, M L | |
700 | 1 | _aBelvisi, M G | |
773 | 0 |
_tBritish journal of pharmacology _gvol. 132 _gno. 8 _gp. 1715-24 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjp.0704022 _zAvailable from publisher's website |
999 |
_c11243889 _d11243889 |